Japan will propose the establishment of a specialized intellectual property body at the Organization for Economic Cooperation and Development (OECD), according to local media reports.
Expanding its patent litigation against one of its chief rivals, U.S. computer maker Hewlett-Packard has petitioned the U.S. International Trade Commission to block Gateway from importing computers.
Canada’s legislature is expected to amend the country’s patent laws this week to let the government issue licenses to companies to produce generic versions of drugs for use in developing countries.
The U.S. Trade Representative has unveiled its closely watched annual list of countries considered the worst offenders of intellectual property rights.
South Korea has formally protested Japan’s ban on imports of Samsung SDI's plasma display panel screens, as patent litigation between Samsung and Fujitsu threatens to escalate to a trade dispute between the two countries.
Canada has amended proposed legislation to allow domestic drug-makers to export generic copies of patented HIV/AIDS drugs to the developing world, stripping patent holders of the “right of first refusal'” over contracts negotiated between developing countries and Canadian generics manufacturers.
In a surprise decision, Russia has adopted amendments to the copyright law that extend copyright protection to 70 years after the author’s death from the current 50 years.
The U.S. International Trade Commission is expected to ban imports of display controllers manufactured by Mstar Semiconductor after determining that the Taiwanese chip maker infringes a patent held by rival Genesis Microchip.
More than two years after China granted patent exclusivity for Pfizer’s Viagra anti-impotence drug, an onslaught of patent challenges has left the drug’s status in limbo, officials at China’s State Intellectual Property Office (SIPO) have conceded.
Indian pharmaceutical companies have urged the government to pass legislation on data protection exclusivity.
Ranbaxy has weighed in on Pfizer’s lawsuit against a website that sells a generic version of blockbuster cholesterol fighter Lipitor, demanding that the vendor stops selling generic drugs that have not been approved for sale in the United States.
Electronics makers Applica and Tilia have settled their litigation over patents for vacuum sealing in a deal under which Applica will pay royalties to use Tilia’s technology.
The U.S. International Trade Commission has voted to begin an investigation into whether some imports of chips used in DVD players and computer optical storage devices infringe on patents held by two California firms.
International law firm Shaw Pittman is planning to open new offices in Silicon Valley and Taiwan in an effort to beef up its intellectual property practice.
Beverage maker Bacardi has filed a lawsuit in federal court in Washington, D.C., seeking a declaratory judgment that Bacardi is the exclusive owner of the Havana Club brand.
Vietnam is preparing a law to streamline earlier intellectual property legislation, according to a senior government official.
Patent applications are rising sharply in China amid growing industry awareness of the need for intellectual property protection, China’s State Intellectual Property Office said.
A Canadian parliamentary committee will review draft legislation Thursday that could pave the way for Canada to sell generic drugs to fight HIV/AIDS, tuberculosis and malaria to developing countries.
Microsoft blasted the E.U.'s €497.2 million antitrust ruling, claiming it would infringe its intellectual property rights.
Alston & Bird has added eight patent, trademark, and copyright attorneys to its New York office from Coudert Brothers, including the head of Coudert’s worldwide IP practice.